Retour sur lavenir.net
   DECEUNINCK 2.195 € (-1,13 %)     ONTEX GROUP 2.530 € (+0,40 %)     FAGRON 23.900 € (-0,21 %)     CAMPINE 216.000 € (+0,93 %)     AB INBEV 74.260 € (+0,65 %)     ARGENX SE 775.800 € (-0,77 %)     MELEXIS 77.250 € (-2,34 %)     ELIA GROUP 139.300 € (-0,29 %)     UCB 256.200 € (-0,16 %)     UMICORE 20.760 € (-2,54 %)     VIOHALCO 19.760 € (+1,33 %)     CENERGY 24.120 € (-0,41 %)     EVS 27.400 € (-1,79 %)     LOTUS BAKERIES 11 480.000 € (+0,53 %)     KBC 117.500 € (-0,30 %)     BARCO 8.315 € (-1,31 %)     D'IETEREN GROUP 171.100 € (-1,38 %)     SOLVAY 26.800 € (-0,67 %)     SOFINA 217.000 € (-1,00 %)     AEDIFICA 71.600 € (+1,49 %)     SYENSQO 67.000 € (0,00 %)     WDP 22.540 € (+1,17 %)     CMB.TECH 12.520 € (-4,72 %)     DEME GROUP 175.600 € (-1,01 %)     TUBIZE-FIN 219.200 € (-0,27 %)     AGEAS 69.450 € (+0,07 %)     GIMV 44.750 € (+1,13 %)     XIOR 26.600 € (+0,76 %)     JENSEN-GROUP 81.600 € (-1,69 %)     QUESTFOR GR-PRICAF 2.980 € (0,00 %)     QRF 10.700 € (-3,17 %)     PROXIMUS 6.095 € (-0,25 %)     ACKERMANS V.HAAREN 285.400 € (-0,56 %)     ONWARD MEDICAL 2.580 € (-1,34 %)     TINC 11.380 € (0,00 %)     KBC ANCORA 80.600 € (+0,25 %)     IBA 16.760 € (+0,60 %)     GBL 78.850 € (-0,32 %)     KINEPOLIS GROUP 35.750 € (+0,28 %)     BPOST 1.564 € (+0,26 %)     VAN DE VELDE 30.000 € (-0,66 %)     AGFA-GEVAERT 0.426 € (-0,70 %)     SIPEF 93.100 € (+0,54 %)     AZELIS GROUP 9.965 € (+0,45 %)     VGP 84.500 € (+0,24 %)     COLRUYT 35.560 € (+1,08 %)     RETAIL ESTATES 70.500 € (+1,00 %)     SHURGARD 25.850 € (+1,37 %)     COFINIMMO 84.250 € (+1,32 %)     HOME INVEST BE. 19.400 € (+0,31 %)     TITAN S.A. 53.150 € (-0,28 %)     BEKAERT 40.100 € (-0,37 %)     ECONOCOM GROUP 1.465 € (-1,68 %)     EKOPAK 3.805 € (+0,13 %)     HYLORIS 4.540 € (-2,37 %)     CARE PROPERTY INV. 12.580 € (+0,32 %)     TESSENDERLO 19.660 € (-1,11 %)     MONTEA 66.700 € (+0,91 %)     RECTICEL 10.780 € (-0,74 %)     BREDERODE 103.200 € (0,00 %)  
   EMEIS 14.400 € (+0,56 %)     FDJ UNITED 20.970 € (-2,01 %)     EXOSENS 50.750 € (-3,61 %)     CVC CAPITAL 12.220 € (-1,29 %)     SBM OFFSHORE 30.360 € (-4,71 %)     EIFFAGE 130.950 € (-0,23 %)     STMICROELECTRONICS 63.100 € (-3,01 %)     AIR FRANCE -KLM 13.945 € (+0,61 %)     LVMH 494.900 € (+0,10 %)     PROSUS 37.470 € (-0,82 %)     AIR LIQUIDE 171.700 € (+0,18 %)     TECHNIP ENERGIES 33.340 € (-2,00 %)     AXA 43.190 € (+0,23 %)     TOTALENERGIES 68.490 € (-1,13 %)     MICHELIN 33.810 € (-0,24 %)     STELLANTIS NV 5.022 € (-1,99 %)     TEIXEIRA DUARTE 0.547 € (+6,01 %)     NN GROUP 76.580 € (+0,05 %)     IMMOB.DASSAULT 48.300 € (-0,21 %)     FUGRO 9.575 € (-3,96 %)     REXEL 37.460 € (+0,43 %)     ADYEN 821.000 € (-0,11 %)     WALLIX 22.550 € (-1,74 %)     ELIOR GROUP 1.928 € (-2,23 %)     THALES 214.200 € (-1,92 %)     SCHNEIDER ELECTRIC 273.050 € (-2,33 %)     SOITEC 110.300 € (-1,74 %)     WOLTERS KLUWER 56.260 € (+0,79 %)     EUROFINS SCIENT. 68.280 € (0,00 %)     SAFRAN 338.700 € (-1,45 %)     PUBLICIS GROUPE SA 86.860 € (+0,32 %)     GL EVENTS 33.350 € (+0,76 %)     EKINOPS 2.690 € (-2,71 %)     ASML HOLDING 1 572.800 € (-1,33 %)     ORANGE 17.135 € (+0,76 %)     DANONE 71.900 € (+2,74 %)     TotalEnergiesGabon 200.000 € (+0,50 %)     DASSAULT AVIATION 285.800 € (-1,18 %)     ENTECH 10.320 € (-2,27 %)     2CRSI 25.200 € (-1,10 %)     L'OREAL 390.200 € (+0,58 %)     MAUREL ET PROM 7.635 € (-0,84 %)     RIBER 11.080 € (-2,29 %)     PHARMING GROUP 1.147 € (-2,01 %)     AVANTIUM 7.520 € (-2,84 %)     RENAULT 26.210 € (0,00 %)     OVH 13.180 € (-1,64 %)     BUREAU VERITAS 25.900 € (-0,19 %)     ASM INTERNATIONAL 960.800 € (-3,05 %)     ACOMO 22.450 € (0,00 %)     CSG 12.316 € (-0,28 %)     ETHERO 0.612 € (-0,49 %)     HERMES INTL 1 621.000 € (+0,46 %)     AIRBUS 193.060 € (-1,04 %)     MAAT PHARMA 2.585 € (-4,44 %)     CRCAM ATL.VEND.CCI 151.700 € (-0,67 %)     BE SEMICONDUCTOR 281.800 € (-2,53 %)     SHELL PLC 33.555 € (-1,42 %)     SEMCO TECHNOLOGIES 47.400 € (-1,96 %)     SOCIETE GENERALE 77.190 € (-1,27 %)  
News Réglementées
06/03/2023 18:17

CEO Stefan Feltens to Retire from SHOP APOTHEKE EUROPE.

EQS-News: SHOP APOTHEKE EUROPE N.V. / Key word(s): Personnel
CEO Stefan Feltens to Retire from SHOP APOTHEKE EUROPE.

06.03.2023 / 18:17 CET/CEST
The issuer is solely responsible for the content of this announcement.


CEO Stefan Feltens to Retire from SHOP APOTHEKE EUROPE.

Sevenum, 6 March 2023. SHOP APOTHEKE EUROPE’s CEO, Stefan Feltens, has informed Björn Söder, chairman of the Supervisory Board that for purely personal reasons, he will not be available for another term after the expiration of his current 4-year term on 26 April 2023 when the company’s Annual General Meeting will be held.

Since Stefan Feltens joined SHOP APOTHEKE EUROPE in September 2018, he contributed to the company’s amazing growth story – from around 3 million customers or half a billion euros in sales four years ago to 9.3 million customers and sales of more than 1.2 billion euros this year. Throughout this period of time, SHOP APOTHEKE EUROPE has continued to enhance its customer value proposition; internal structures and processes have been established or improved to prepare the company for continuous growth in the future.

Stefan Feltens comments his decision: “It has been a tremendous privilege to serve SHOP APOTHEKE EUROPE over the last years. I remain fully convinced that the company is poised for a great future – in terms of attracting and serving many more customers, offering great development opportunities for its employees, but also meeting the expectations of its shareholders. Great teamwork has been the genesis of SHOP APOTHEKE EUROPE‘s success to date. In my mind there is no doubt that such teamwork will take the company to new heights in the future.”

After the company’s Annual General Meeting on 26 April, Stefan will remain with SHOP APOTHEKE EUROPE until the end of May to ensure a smooth handover of his responsibilities. Afterwards, Stefan will continue to support SHOP APOTHEK EUROPE as a special advisor on an as-needed basis.

CCO, Deputy CEO and co-founder of SHOP APOTHEKE EUROPE Stephan Weber: “In the last four years, Stefan has managed to  professionalise the company significantly in all relevant areas. Thanks to him our company’s structures, processes and strategy are firmly in place to continue our success story with further growth in Europe. Moreover, we thank Stefan for the super exciting time together and for the many things we learned from him on a professional and personal level. We all wish him only the best for the future.“

The company’s Supervisory Board, which is in charge of nominations to the Executive Management, has already initiated an external search for Stefan’s successor. From the date of the Annual General Meeting until a new CEO is on board, Stefan’s current responsibilities will be managed by his fellow members of the Managing Board.

Björn Söder, chairman of the SHOP APOTHEKE EUROPE’s Supervisory Board: "We are extremely grateful for Stefan Felten’s contribution to the success of SHOP APOTHEKE EUROPE. During his leadership, we reached many important strategic milestones while balancing strong growth with improved profitability. We are sorry to lose him, but wish him all the best for his personal future."

 

ABOUT SHOP APOTHEKE EUROPE.

SHOP APOTHEKE EUROPE is one of Europe’s leading and fastest-growing online pharmacies, currently operating in Germany, Austria, France, Belgium, Italy, the Netherlands and Switzerland.


Headquartered in the Dutch logistics hub of Sevenum near Venlo with locations in Cologne, Berlin, Munich, Tongeren, Warsaw, Milan, Lille and Eindhoven, SHOP APOTHEKE EUROPE offers its customers a broad range of more than 100,000 original products at attractive prices: OTC, beauty and personal care products as well as prescription drugs, supplemented by high quality natural food and health products, low carb products and sports nutrition. Currently, over 9 million active customers trust SHOP APOTHEKE EUROPE.


Since safe and reliable pharmaceutical advice are top priorities at SHOP APOTHEKE EUROPE, the e-pharmacy provides comprehensive pharmaceutical consulting services. In preparation for the full introduction of the electronic prescriptions in Germany, the company is continuously expanding in the area of digital health services.


SHOP APOTHEKE EUROPE N.V. has been listed on the regulated market of the Frankfurt Stock Exchange (Prime Standard) since 2016 and is part of the SDAX stock index.

 

 



06.03.2023 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


Language:English
Company:SHOP APOTHEKE EUROPE N.V.
Erik de Rodeweg 11-13
5975 WD Sevenum
Netherlands
Phone:0800 - 200 800 300
Fax:0800 - 90 70 90 20
E-mail:Investor.Relations@shop-apotheke.com
Internet:www.shop-apotheke-europe.com
ISIN:NL0012044747, DE000A19Y072
WKN:A2AR94, A19Y07
Indices:SDAX
Listed:Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange
EQS News ID:1575833

 
End of NewsEQS News Service

1575833  06.03.2023 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1575833&application_name=news&site_id=symex

Source : Webdisclosure.com

© 2026 Tous droits réservés
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière